Product Name:

TrkB-pY702


Product Number:

ab-pk839

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: BNDF/NT3/4/5 receptor- tyrosine kinase

Target Alias: GP145-TrkB; GP145-TrkB,GP95-TrkB; NTrk2; CCDS6671.1; ENSG00000148053

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK839

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y702

Protein UniProt: Q16620

Protein SigNET: Q16620

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human TrkB (NTrk2) sequence peptide Cat. No.: PE-04AQE95

Antibody Immunogen Sequence: RDV(pY)STD(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues R699 to D705; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.

Production Method: Corresponds to amino acid residues R699 to D705; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Medium immunoreactivity with immunogen peptide on dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 85-95 kDa.

Scientific Background: TrkB is one of several protein kinases that can phosphorylate KinSub5DDDYV. TrkB is a receptor protein-tyrosine kinase that is a member of the TK group of protein kinases in the Trk family. This kinase shows high variability in human tissue distribution with the highest levels detected in brain, ovary, pancreas, pituitary, spinal cord, thyroid and trachea. TrkB is activated by binding BDNF, NT-3, NT-4 or NT-5, which induce dimerization and autophosphorylation. Phosphorylation at Y516 increases phosphotransferase activity and induces interaction with PLCg1. TrkB activation stimulates signalling throught the MAPK pathway. Signalling through TrkB leads to cell differentiation. Mutations in the TrkB gene have been associated with obesity and mood disorders. TrkB has also been linked with the development of colon and lung cancers, neuroblastomas and pilocytic astrocytomas, which are benign tumours of the brain or spinal cord that grow slowly.